Our Mission

"Our research is imperative for medical science moving into the future - and we're uniquely equipped to advance this field and address unmet needs for patients around the world."

Kevin Heyeck, CEO, Chimeron Bio

Dedicated to advancing genetic medicine and transforming cancer treatment. 

Our groundbreaking therapies leverage innovative science to achieve unparallelled gene expression and therapeutic potency, positioning us at the forefront of developing breakthrough enhanced in vivo CAR-T therapies.


We are also pioneering breakthroughs in immuno-oncology and cancer vaccines- offering new hope in the battle against cancer.